· 个股论点

看好 $SIVE 作为高贝塔光通信标的,受益于激光器瓶颈及潜在并购。

涉及标的:

相关概念: CPO 共封装光学光子学 Photonics

中文翻译

@Blazedsin 是的,$SIVE 是我首选的高贝塔(High-Beta)光通信多头标的。 这是一家小型公司,为以下领域供应激光器: - 像 $JBL 这样提供可插拔模块的可插拔模块供应商。 - 与 $POET / O-Net 合作的外部光引擎(ELS)+ 光引擎。 - 与 Ayar 等公司合作的光 I/O 扩展。 - 像 $GFS 这样的光子代工(Photonic Foundries),涵盖 NPO/可插拔/CPO 等所有架构。 随着 Win Semi 的独立连续波(CW)产能投产,正值结构性瓶颈期……纳斯达克上市可能在接下来几个季度实现。 而且 CEO 确实懂行 + 与股东利益一致(在二级市场买入股票),稀释程度低就能完成这一切。 他们还暗示了并购(M&A),这对总可寻址市场(TAM)扩张很理想(看看 2023 年下半年 Cloud Light 并购 Lumentum 后发生了什么)。 然后你有 $MTSI,$AAOI 可能不会实质性参与第一代共封装光学(CPO)部署(参与者池较小)……行业目前面临连续波(CW)短缺,随后才是量产爬坡。针对中国竞争的监管顺风。 我不确定是不是只有我觉得,他们拥有理想的布局,主要缺点是仅在某个小型瑞典交易所上市,这损害了估值。

英文原文

@Blazedsin Yeah, $SIVE is my favorite high-beta optical long. You have a small company supplying lasers for: - Hyperscaler suppliers like $JBL with pluggables. - ELS + optical engines with $POET / O-Net. - Scale up with optical I/O with Ayar and others. - Photonic Foundries like $GFS across all architectures like NPO/pluggables/CPO. with independent CW capacity coming online with Win Semi during a structural bottleneck... NASDAQ listing likely in the next few quarters. And the CEO actually knows what he's doing + aligned with shareholders (in terms of buying stock on the open market), with low dilution to get all of this done. And they hinted at M&A, which is ideal for TAM expansion (look at what happened with Lumentum after Cloud Light H2 2023 M&A). Then you have $MTSI, $AAOI likely no meaningful participating in first-gen CPO deployments (smaller pool of players)... Industry CW shortages currently before volume ramp. Regulation tailwinds targeting Chinese competition. I'm not sure if it's just me but they have the ideal setup, main downside is that it's just listed on some small Swedish exchange and that harms valuations.

在 X 上查看原推 ↗